Related Experiment Video
Updated: Jun 10, 2026

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
Published on: September 19, 2025
Personalized medicine in oncology: tailoring the right drug to the right patient
1Veridex, LLC, a Johnson & Johnson Company, Raritan, NJ, USA.
Abstract:
Despite advances in the management of many human cancers over the past few decades, improvements in survival are marginal, and the overall diagnosis and prognosis for cancer patients remain poor. Tailoring therapy to the individual patient has become a promising approach for maximizing efficacy and minimizing drug toxicity. Aided by major technological advances, the field of personalized medicine has become extremely active in the identification of predictive biomarkers that can guide treatment decisions and, ultimately, improve treatment outcomes. Genomics and proteomics have provided a means for molecular profiling that allows tailoring of therapy. Although implementing genomic and proteomic testing into clinical practice is still in its infancy, the rapid development of newer technologies and platforms provides hope for personalized medicine.
Insights
Personalized medicine uses genomics and proteomics to tailor cancer treatments, aiming to improve patient survival and reduce toxicity. Advances in molecular profiling offer hope for more effective cancer care.
Area of Science:
- Oncology
- Genomics
- Proteomics
Background:
- Cancer treatment advances have yielded marginal survival improvements.
- Current cancer diagnosis and prognosis remain suboptimal for many patients.
Purpose of the Study:
- To highlight the potential of personalized medicine in oncology.
- To discuss the role of genomics and proteomics in tailoring cancer therapy.
- To emphasize the need for predictive biomarkers in cancer treatment.
Main Methods:
- Molecular profiling using genomics and proteomics.
- Identification of predictive biomarkers for treatment decisions.
Main Results:
- Genomics and proteomics enable tailored cancer therapy.
- Personalized medicine approaches show promise for improving efficacy and minimizing toxicity.
Conclusions:
- Personalized medicine, driven by molecular profiling, offers a promising strategy for improving cancer patient outcomes.
- Continued technological development is crucial for integrating genomic and proteomic testing into clinical practice.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Dosage Regimen: Individualization
Pharmacogenomics: Identification of New Drug Targets
